Asthma and care during a coronavirus pandemic
Autor(a) principal: | |
---|---|
Data de Publicação: | 2021 |
Outros Autores: | , , , , |
Tipo de documento: | Artigo |
Idioma: | por |
Título da fonte: | Vittalle (Online) |
Texto Completo: | https://periodicos.furg.br/vittalle/article/view/12374 |
Resumo: | The new coronavirus, discovered in December 2019, is the causative agent of severe pneumonia that has spawned a global pandemic. The recognition of risk and protection factors are essential to guide the follow-up of new treatments and infection prevention strategies. This study aims to assess the influence of asthma against the pandemic due to the new coronavirus, with regard to the pathophysiology of pathological conditions, risk factors, therapeutic forms, associated comorbidities and the current protocols that are being used in such a scenario. The study is based on an integrative research of narrative literature review. In order to establish the relationship between asthma and COVID-19, articles published in the years 2019 and 2020 were limited to the PubMed and BVS virtual libraries. Asthma is a chronic respiratory disease characterized by inflammation of the airways, hyperresponsiveness, exacerbated mucus production and remodeling. The most frequent trigger of the pathology is airway infection, especially of viral origin. The asthmatic patient's innate immune system is unable to prevent the spread of these viruses to the lower respiratory tract. Currently, the Center for Disease Control and Prevention and the World Health Organization suggest that patients with moderate and severe asthma may be at higher risk for severe cases of SARS-CoV-2 infection, however, in the literature, there are no findings that corroborate. Therefore, he sees that the study and new associations must be continued, in order to better understand the relationship between asthma and COVID-19. Keywords: COVID-19. Asthma. Risk factor. |
id |
FURG-6_1ee8a69bb11c28947153cfe28d8aec6c |
---|---|
oai_identifier_str |
oai:periodicos.furg.br:article/12374 |
network_acronym_str |
FURG-6 |
network_name_str |
Vittalle (Online) |
repository_id_str |
|
spelling |
Asthma and care during a coronavirus pandemicReflexo da COVID-19 em asmáticosCOVID-19asmafator de riscoThe new coronavirus, discovered in December 2019, is the causative agent of severe pneumonia that has spawned a global pandemic. The recognition of risk and protection factors are essential to guide the follow-up of new treatments and infection prevention strategies. This study aims to assess the influence of asthma against the pandemic due to the new coronavirus, with regard to the pathophysiology of pathological conditions, risk factors, therapeutic forms, associated comorbidities and the current protocols that are being used in such a scenario. The study is based on an integrative research of narrative literature review. In order to establish the relationship between asthma and COVID-19, articles published in the years 2019 and 2020 were limited to the PubMed and BVS virtual libraries. Asthma is a chronic respiratory disease characterized by inflammation of the airways, hyperresponsiveness, exacerbated mucus production and remodeling. The most frequent trigger of the pathology is airway infection, especially of viral origin. The asthmatic patient's innate immune system is unable to prevent the spread of these viruses to the lower respiratory tract. Currently, the Center for Disease Control and Prevention and the World Health Organization suggest that patients with moderate and severe asthma may be at higher risk for severe cases of SARS-CoV-2 infection, however, in the literature, there are no findings that corroborate. Therefore, he sees that the study and new associations must be continued, in order to better understand the relationship between asthma and COVID-19. Keywords: COVID-19. Asthma. Risk factor.O novo coronavírus, descoberto em dezembro de 2019, é o agente causador da pneumonia grave que gerou uma pandemia global. O reconhecimento dos fatores de risco e proteção são essenciais para direcionar o seguimento de novos tratamentos e estratégias de prevenção de infecções. Este estudo tem como objetivo avaliar a influência da asma frente a pandemia pelo novo coronavírus, no que tange à fisiopatologia dos quadros patológicos, aos fatores de risco, às formas terapêuticas, às comorbidades associadas e aos atuais protocolos que estão sendo utilizados em tal cenário. O estudo baseia-se em uma pesquisa descritiva de revisão integrativa da literatura. Limitou-se, para estabelecer a relação da asma e COVID-19, artigos publicados nos anos de 2019 e 2020, nas bibliotecas virtuais PubMed e BVS. Asma é uma doença respiratória crônica caracterizada pela inflamação das vias aéreas, hiper-responsividade, produção exacerbada de muco e remodelação. O gatilho mais frequente da patologia é a infecção das vias aéreas, especialmente de origem viral. O sistema imunológico inato do paciente asmático é incapaz de impedir a disseminação desses vírus para as vias respiratórias inferiores. Atualmente, o Centro de Controle e Prevenção de Doenças e a Organização Mundial de Saúde sugerem que pacientes com asma moderada e grave podem estar em maior risco para os casos graves de infecção pelo SARS-CoV-2, entretanto, na literatura, não há achados que corroboram. Sendo assim, vê que o estudo e novas associações devem ser continuados, a fim de melhor compreender a relação entre a asma e a COVID-19.Universidade Federal do Rio Grande2021-08-09info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionapplication/pdfhttps://periodicos.furg.br/vittalle/article/view/1237410.14295/vittalle.v33i2.12374VITTALLE - Revista de Ciências da Saúde; v. 33 n. 2 (2021); 12 - 192177-78531413-3563reponame:Vittalle (Online)instname:Universidade Federal do Rio Grande (FURG)instacron:FURGporhttps://periodicos.furg.br/vittalle/article/view/12374/8952Copyright (c) 2021 VITTALLE - Revista de Ciências da Saúdeinfo:eu-repo/semantics/openAccessSantos Lins de Oliveira, GuilhermeCavalcanti Pires de Azevedo, ThomásAguiar Costa, Rayane Gomes de Mendonça Vasconcelos, Júlia MariaMonteiro da Cruz, CristianeReis Gonçalves, Marcos2021-08-09T14:05:14Zoai:periodicos.furg.br:article/12374Revistahttps://periodicos.furg.br/vittallePUBhttps://periodicos.furg.br/vittalle/oaivittalle@furg.br2177-78531413-3563opendoar:2021-08-09T14:05:14Vittalle (Online) - Universidade Federal do Rio Grande (FURG)false |
dc.title.none.fl_str_mv |
Asthma and care during a coronavirus pandemic Reflexo da COVID-19 em asmáticos |
title |
Asthma and care during a coronavirus pandemic |
spellingShingle |
Asthma and care during a coronavirus pandemic Santos Lins de Oliveira, Guilherme COVID-19 asma fator de risco |
title_short |
Asthma and care during a coronavirus pandemic |
title_full |
Asthma and care during a coronavirus pandemic |
title_fullStr |
Asthma and care during a coronavirus pandemic |
title_full_unstemmed |
Asthma and care during a coronavirus pandemic |
title_sort |
Asthma and care during a coronavirus pandemic |
author |
Santos Lins de Oliveira, Guilherme |
author_facet |
Santos Lins de Oliveira, Guilherme Cavalcanti Pires de Azevedo, Thomás Aguiar Costa, Rayane Gomes de Mendonça Vasconcelos, Júlia Maria Monteiro da Cruz, Cristiane Reis Gonçalves, Marcos |
author_role |
author |
author2 |
Cavalcanti Pires de Azevedo, Thomás Aguiar Costa, Rayane Gomes de Mendonça Vasconcelos, Júlia Maria Monteiro da Cruz, Cristiane Reis Gonçalves, Marcos |
author2_role |
author author author author author |
dc.contributor.author.fl_str_mv |
Santos Lins de Oliveira, Guilherme Cavalcanti Pires de Azevedo, Thomás Aguiar Costa, Rayane Gomes de Mendonça Vasconcelos, Júlia Maria Monteiro da Cruz, Cristiane Reis Gonçalves, Marcos |
dc.subject.por.fl_str_mv |
COVID-19 asma fator de risco |
topic |
COVID-19 asma fator de risco |
description |
The new coronavirus, discovered in December 2019, is the causative agent of severe pneumonia that has spawned a global pandemic. The recognition of risk and protection factors are essential to guide the follow-up of new treatments and infection prevention strategies. This study aims to assess the influence of asthma against the pandemic due to the new coronavirus, with regard to the pathophysiology of pathological conditions, risk factors, therapeutic forms, associated comorbidities and the current protocols that are being used in such a scenario. The study is based on an integrative research of narrative literature review. In order to establish the relationship between asthma and COVID-19, articles published in the years 2019 and 2020 were limited to the PubMed and BVS virtual libraries. Asthma is a chronic respiratory disease characterized by inflammation of the airways, hyperresponsiveness, exacerbated mucus production and remodeling. The most frequent trigger of the pathology is airway infection, especially of viral origin. The asthmatic patient's innate immune system is unable to prevent the spread of these viruses to the lower respiratory tract. Currently, the Center for Disease Control and Prevention and the World Health Organization suggest that patients with moderate and severe asthma may be at higher risk for severe cases of SARS-CoV-2 infection, however, in the literature, there are no findings that corroborate. Therefore, he sees that the study and new associations must be continued, in order to better understand the relationship between asthma and COVID-19. Keywords: COVID-19. Asthma. Risk factor. |
publishDate |
2021 |
dc.date.none.fl_str_mv |
2021-08-09 |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article info:eu-repo/semantics/publishedVersion |
format |
article |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
https://periodicos.furg.br/vittalle/article/view/12374 10.14295/vittalle.v33i2.12374 |
url |
https://periodicos.furg.br/vittalle/article/view/12374 |
identifier_str_mv |
10.14295/vittalle.v33i2.12374 |
dc.language.iso.fl_str_mv |
por |
language |
por |
dc.relation.none.fl_str_mv |
https://periodicos.furg.br/vittalle/article/view/12374/8952 |
dc.rights.driver.fl_str_mv |
Copyright (c) 2021 VITTALLE - Revista de Ciências da Saúde info:eu-repo/semantics/openAccess |
rights_invalid_str_mv |
Copyright (c) 2021 VITTALLE - Revista de Ciências da Saúde |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
application/pdf |
dc.publisher.none.fl_str_mv |
Universidade Federal do Rio Grande |
publisher.none.fl_str_mv |
Universidade Federal do Rio Grande |
dc.source.none.fl_str_mv |
VITTALLE - Revista de Ciências da Saúde; v. 33 n. 2 (2021); 12 - 19 2177-7853 1413-3563 reponame:Vittalle (Online) instname:Universidade Federal do Rio Grande (FURG) instacron:FURG |
instname_str |
Universidade Federal do Rio Grande (FURG) |
instacron_str |
FURG |
institution |
FURG |
reponame_str |
Vittalle (Online) |
collection |
Vittalle (Online) |
repository.name.fl_str_mv |
Vittalle (Online) - Universidade Federal do Rio Grande (FURG) |
repository.mail.fl_str_mv |
vittalle@furg.br |
_version_ |
1797041721215811584 |